Antimicrobial resistance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated from children with community-acquired respiratory tract infection treated at IP-CZD from 1999 to 2002;Analiza wrażliwości Streptococcus pneumoniae, Haemophilus influenzae i Moraxella catarrhalis wyodrȩbnionych z materiałów klinicznych od dzieci z zakażeniami dróg oddechowych leczonych w IP-CZD w latach 1999-2002

Pediatria Polska

Volumn 78, Issue 3, 2003, Pages 173-181

  Semczuk, Katarzyna ^a   Łopaciuk, Urszula ^a   Dzierzanowska Fangrat, Katarzyna ^a   Gabińska, Ewa ^a   Dmeńska, Hanna ^a   Dzierzanowska, Danuta ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

Haemophilus influenzae; Moraxella catarrhalis; Streptococcus pneumoniae

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE; CEFACLOR; CEFOTAXIME; CEFUROXIME; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CHILD; COMMUNICABLE DISEASE; DRUG EFFICACY; HAEMOPHILUS INFLUENZAE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; PENICILLIN RESISTANCE; POLAND; RESPIRATORY TRACT INFECTION; STREPTOCOCCUS PNEUMONIAE;

EID: 0242684468     PISSN: 00313939     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Cappelletty D.: Microbiology of bacterial respiratory infections. Pediat. Inf. Dis. J., 1998, 17(S): S55-61.
2. Johnson J. A.: Pathogenesis of bacterial infections of the respiratory tract. Brit. J. Biomed. Sci., 1995, 52: 157-161.
3. Dzierzanowska D.: Antybiotykoterapia praktyczna., α-medica press, Bielsko-Biała, 2000.
4. Felmingham D., Washington J.: The Alexander Project Group. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens - findings of the Alexander Project 1992-1996. J. Chemother., 1999; 11: 5-21.
5. Sethi S.,Murphy T. F.: Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review. Clin. Microbiol. Riv., 2001, 14, 2: 336-363.
6. National Committee for Clinical Laboratory Standards. 2001, 21, 1.M100-S11.
7. Brook I.: Microbial factors leading to recurrent upper respiratory tract infections. Pediat. Inf. Dis. J., 1998, 17(S): S62-67.
8. McCracken Jr G. H.: Diagnosis management of pneumonia in children. Pediat. Inf. Dis. J., 2002, 19: 924-928.
9. Felmingham D., Grüneberg R. N.: The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J. Antimicrob. Chemother. 2000, 45: 191-203.
10. Schito G. C., Debbia E. A., Marchese A.: The evolving of antibiotic resistance in Europe: new data from the Alexander Project. J. Antimicrob. Chemother. 2000, 46, T1: 3-9.
11. Overweg K. i in.: Multidrug-Resistant Streptococcus pneumoniae in Poland: Identyfication of Emerging Clones. J. Clin. Microbiol. 1999, 37, 6: 1739-1745.
12. www.rsp.pl
13. Fenoll A. i in.: Streptococcus pneumoniae in children in Spain: 1990-1999. A. Paediatr Suppl 2000, 435: 44-50.
14. Richard M. P. i in.: Sensitivity to sparfloxacin and other antibiotics, of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis strains isolated from adult patients with community-acquired lower respiratory tract infections: a European multicentre study. J. Antimicrob. Chemother. 1998, 41: 207-214.
15. Gaudeus J., Cohen R., Reinert P.: Epidemiology of pneumococcal infections in French children. A. Paediatr. Supppl 2000, 435, 27-29.
16. Sahm D. F. i in.: Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998. J. Antimicrob. Chemother. 2000, 45: 457-466.
17. Garcia-Rey C. i in.: Imortance of Local Variations in Antibiotic Consumption and Geographical Differences of Erythromycin and Penicillin Resistance in Streptococcus pneumoniae. J. Clin. Microbiol. 2002, 40, 1: 159-164.
18. Goldstein F. W.: Penicillin-resistant Streptococcus pneumoniae: selection by both β-lactam and non β-lactam antibiotics. J. Antimicrob. Chemother. 1999, 44: 141-144.
19. Karlowsky J. A. i in.: Antimicrobial Surveillance of Haemophilus influenzae in the United States during 2000-2001 Leads to Detection of Clonal Dissemination of a β-Lactamase-Negative and Ampicillin-Resistant Strain. J. Clin. Microbiol. 2002, 40, 3: 1063-1066.
20. Markowitz J. A. i in.: Antimicrobial Surveillance of Haemophilus influenzae in the United States during 2000-2001 Leads to Detection of Clonal Dissemination of a β-Lactamase-Negative and Ampicyllin-Resistant Strain. J. Clin. Microbiol. 2002, 40, 3: 1063-1066.
21. Schmitz F-J. i in.: Production of BRO β-Lactamases and Resistance to Complement in Europen Moraxella catarrhalis Isolates. J. Clin. Microbiol. 2002, 40, 4: 1546-1548.